Marc Boutin, VP & COO, Discusses a Proposal to Promote Personalized Healthcare

Sunday, May 29, 2011

BioCentury This Week features an interview with NHC Executive Vice President and COO Marc Boutin on a proposal to promote personalized health care, create a new category of drugs called dormant therapies, and encourage the development of treatments and cures for patients with unmet medical needs.